Second Affiliated Hospital, Zhejiang University, School of Medicine
Intracerebral hemorrhage (ICH) remains a devastating disease with high mortality, yet few therapeutic managements have been proved effective. Large quantities of work needs to be done to fully delineate the prevalence and prognosis of ICH. Hence, the investigators design a prospective, observational cohort study to provide contemporary information on the prevalence, characteristics, risk stratification,cost-effective, treatments and prognosis of Chinese hospitalised adult patients with ICH.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Hospitalized patients over 18 years old of primary intracerebral hemorrhage.
You may not be if
1. patients of secondary intracerebral hemorrhage,such as hemorrhagic transformation of ischemic stroke, aneurysmal, cavernomas, arterio- venous malformations, central venous thrombosis, trauma-related, or tumor.
2. isolated intraventricular hemorrhage or subarachnoid hemorrhage pregnant patients;
3. surgical evacuation of hematoma;
4. unavailability to get complete blood cell samples and presenting contraindications or refusal to MRI
5. patients cannot be followed up for any reasons.